2.29 USD
↘ 0.51 (18.20%)AT CLOSE (03:59 PM EDT)
Propanc Biopharma, Inc. Common Stock
PPCBNASDAQ • USD
2.21
↘ 0.08 (3.71%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
2.21
↘ 0.08 (3.71%)
Market: CLOSED
PPCB is currently priced at $2.34. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 26, 2026.
Open?$3.00
High?$3.01
Low?$2.21
Prev. Close?$2.80
Volume?104.2K
Avg. Volume?340.5K
VWAP?$2.58
Rel. Volume?0.31x
Bid / Ask
Bid?$2.20 × 2.3K
Ask?$2.23 × 200
Spread?$0.03
Midpoint?$2.22
Valuation & Ratios
Market Cap?22.5M
Shares Out?10.3M
Float?2.5M
Float %?71.3%
P/E Ratio?N/A
P/B Ratio?2.39
EPS?-$2.01
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Themes
Address
302/6 BUTLER STREET
CAMBERWELL, VICTORIA, C3 3124
Phone: 61-03-9882-0780
CAMBERWELL, VICTORIA, C3 3124
Phone: 61-03-9882-0780
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?80
Piotroski F-Score?0/9Weak
Altman Z-Score?-16.04Distress
Confidence?23%Very Low
Short InterestLow
Short % of Float?2.02%Low
Short Interest?50.5K
Days to Cover?1.0
Free Float2.5M
Avg Daily Volume285.4K
Settlement Date2026-10-15
Financial Health
Current Ratio?2.55Strong
Quick Ratio?2.55Strong
Cash Ratio?0.25Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.39CHEAP▾
Peers100
S&P66
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-210.6%WEAK▾
S&P3
ROA?-154.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-5687568
Enterprise Value?$21.7M
Fundamentals ratios updated end of day